Macquarie initiated coverage of CoreWeave (CRWV) with a Neutral rating and $56 price target. While the firm likes CoreWeave’s approach, the AI outlook, and contracted revenues, the current price reflects the structural positives and near-term execution risk amid site development in intermediate stages across Core Scientific (CORZ)/Helios, the analyst tells investors in a research note. The firm says the bulk of its forecast revenue growth through 2030 is already locked in.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRWV:
- CoreWeave Expands Credit Facility to $1.5 Billion
- Largest borrow rate increases among liquid names
- ‘Don’t Buy It Yet,’ Says Analyst about CoreWeave Stock (CRWV)
- AI Daily: Google can train AI products with content even after opt-out
- Microsoft downgraded, Reddit upgraded: Wall Street’s top analyst calls